Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$T, $ABT, $BSX, $HON, $MRVL

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Thursday, as follows:

AT&T Inc. (NYSE:T) was resumed in coverage at Morgan Stanley with an Overweight rating and a 37 price objective. That compares to the Wall Street consensus price target of 37.35.

Abbott Laboratories (NYSE:ABT) was started with a Buy rating at Bernstein, which has a 73 price target. The consensus price target for the pharmaceutical giant is set at 68.40.

Boston Scientific Corp. (NYSE:BSX) was started with an Outperform rating and a 38 price target at Bernstein. That compares with the consensus target of 33.20.

Honeywell International Inc. (NYSE:HON) was started with an Outperform rating and a 170 price target at Wolfe Research. The consensus target is 172.12.

Marvell Technology Group Ltd. (NASDAQ:MRVL) was raised to Buy from Hold at Deutsche Bank. The shares have traded in a 52-wk range of 14.87 – 25.18. The consensus price target is 27.89.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :  
CONNECT WITH